Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible? (2014)

  • Authors:
  • USP affiliated authors: FAINTUCH, JOEL - FM ; RIBEIRO JÚNIOR, ULYSSES - FM ; CECCONELLO, IVAN - FM
  • USP Schools: FM; FM; FM
  • DOI: 10.1007/s11695-014-1277-z
  • Subjects: CIRURGIA BARIÁTRICA; BACTÉRIAS AERÓBICAS; BACTÉRIAS ANAERÓBICAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11695-014-1277-z (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Obesity Surgery

    ISSN: 0960-8923

    Citescore - 2017: 2.92

    SJR - 2017: 1.396

    SNIP - 2017: 1.219


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2657169-10BCSEP 163 2014
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ISHIDA, Robson K.; FAINTUCH, Joel; RIBEIRO, Adriana Safatle; RIBEIRO JR., Ulysses; CECCONELLO IVAN,. Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible? Obesity Surgery, New York, v. 24, n. 11, p. 1856-1861, 2014. Disponível em: < http://link.springer.com/article/10.1007/s11695-014-1277-z > DOI: 10.1007/s11695-014-1277-z.
    • APA

      Ishida, R. K., Faintuch, J., Ribeiro, A. S., Ribeiro Jr., U., & Cecconello Ivan,. (2014). Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible? Obesity Surgery, 24( 11), 1856-1861. doi:10.1007/s11695-014-1277-z
    • NLM

      Ishida RK, Faintuch J, Ribeiro AS, Ribeiro Jr. U, Cecconello Ivan. Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible? [Internet]. Obesity Surgery. 2014 ; 24( 11): 1856-1861.Available from: http://link.springer.com/article/10.1007/s11695-014-1277-z
    • Vancouver

      Ishida RK, Faintuch J, Ribeiro AS, Ribeiro Jr. U, Cecconello Ivan. Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible? [Internet]. Obesity Surgery. 2014 ; 24( 11): 1856-1861.Available from: http://link.springer.com/article/10.1007/s11695-014-1277-z

    Referências citadas na obra
    Schmalstieg Jr FC, Goldman AS. Ilya Ilich Metchnikoff (1845-1915) and Paul Ehrlich (1854-1915): the centennial of the 1908 Nobel Prize in Physiology or Medicine. J Med Biogr. 2008;16:96–103.
    Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590–8.
    Karlsson F, Tremaroli V, Nielsen J, et al. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013;62:3341–9.
    Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–8.
    Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011;9:461–9.
    Yu D, Cheeseman F, Vanner FS. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–40.
    Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178–41.
    Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6. e7.
    Ockeloen LE, Deckers-Kocken JM. Short- and long-term effects of a lactose-restricted diet and probiotics in children with chronic abdominal pain: a retrospective study. Complement Ther Clin Pract. 2012;18:81–4.
    Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371–7.
    Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–87.
    Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56:1524–34.
    Madrid AM, Poniachik J, Quera R, et al. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011;56:155–60.
    Machado JD, Campos CS, Lopes Da Silva C, et al. Intestinal bacterial overgrowth after Roux-em-Y gastric bypass. Obes Surg. 2007;17:1529–33.
    Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483–90.
    Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107:730–5.
    George NS, Sankineni A. Parkman HP. Dig Dis Sci: Small intestinal bacterial overgrowth in gastroparesis; 2012.
    Klaus A, Weiss H, Kreczy A, et al. A new biliodigestive anastomosis technique to prevent reflux and stasis. Am J Surg. 2001;182:52–7.
    Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28:293–8.
    Corrodi P. Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infec Dis. 1984;6 Suppl 1:S80–4.
    Leung FW, Drenick EJ, Stanley TM. Intestinal bypass complications involving the excluded bowel segment. Am J Gastroenterol. 1982;77:67–72.
    Rana SV, Sharma S, Kaur J, et al. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243–7.
    Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63:1–9.
    Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198–204.
    Shin DW, Kwon HT, Kang JM, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–5.
    Steineman DC, Bueter M, Schiesser M, Amygdalos I, Clavien PA, Nocito A. Management of anastomotic ulcers after Roux-en-Y Gastric Bypass: results of an International Survey. Obes Surg 2013 Dec 18
    Petrof EO, Claud EC, Gloor GB, et al. Microbial ecosystems therapeutics: a new paradigm in medicine ? Benef Microbes. 2013;4:53–65.
    Allen-Vercoe E, Reid G, Viner N, et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol. 2012;26:457–62.
    Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1:3–9.